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ABSTRACT
We have developed a set of web-based SNP selec-
tion tools (freely available at http://www.niehs.nih.
gov/snpinfo) where investigators can specify
genes or linkage regions and select SNPs based
on GWAS results, linkage disequilibrium (LD), and
predicted functional characteristics of both coding
and non-coding SNPs. The algorithm uses GWAS
SNP P-value data and finds all SNPs in high LD
with GWAS SNPs, so that selection is from a much
larger set of SNPs than the GWAS itself. The pro-
gram can also identify and choose tag SNPs
for SNPs not in high LD with any GWAS SNP. We
incorporate functional predictions of protein struc-
ture, gene regulation, splicing and miRNA binding,
and consider whether the alternative alleles of a
SNP are likely to have differential effects on func-
tion. Users can assign weights for different func-
tional categories of SNPs to further tailor SNP
selection. The program accounts for LD structure
of different populations so that a GWAS study from
one ethnic group can be used to choose SNPs for
one or more other ethnic groups. Finally, we provide
an example using prostate cancer and demonstrate
that this algorithm can select a small panel of SNPs
that include many of the recently validated prostate
cancer SNPs.
INTRODUCTION
The completion of the International HapMap Project (1)
and the development of advanced genotyping technologies
have made genome-wide association studies (GWAS) pos-
sible. These studies typically genotype more than 1000
cases and 1000 controls for 300K to 1 million SNPs. A
number of GWAS have been published with many more in
progress (2–4). A number of disease-associated SNPs have
been identiﬁed and conﬁrmed by these breakthrough stud-
ies with many more yet to come. Repeating GWAS
in additional individuals has helped to ﬁnd more dis-
ease-associated SNPs, although doing so is costly.
Interestingly, the SNPs identiﬁed and subsequently con-
ﬁrmed in large replication samples are not always those
with the smallest P-value in the GWAS, and two GWAS
may have radically diﬀerent P-values assigned to a con-
ﬁrmed SNP. For example, in prostate cancer a conﬁrmed
SNP in MSMB from the initial GWAS had a P-value of
only 0.042, but the P-value was 7.31 10
–13 in a follow up
study (4,5). Thus the list of potential SNPs from any
GWAS remains large. This large SNP list poses a problem
for validation studies where a very large number of people
are genotyped because custom arrays can cost more than
standard GWAS arrays.
For many diseases there exists a rich, diverse and
growing literature that can be used to identify genes and
chromosomal regions of high interest. This literature
includes existing genetic studies of linkage and candidate
genes as well as research on disease pathogenesis. For
example, information about disrupted cell signaling path-
ways and genomic-level expression data from comparisons
of tumor and normal tissues have identiﬁed interesting
candidate genes for cancer. Thus investigators may
have a large but ﬁnite set of genes and genomic regions
that they feel deserve particular scrutiny or they may
have a special interest in certain genes or chromosomal
regions.
Agnostic GWAS data provide a unique opportunity for
hypothesis driven candidate gene exploration, but the
sheer size and complexity of GWAS data can be diﬃcult
to manage. Although it may not be diﬃcult to ﬁnd which
SNPs of a gene are directly included in a GWAS panel, it
is harder to determine which additional SNPs are tagged
by the panel, particularly when examining multiple ethnic
groups where linkage disequilibrium (LD) structure and
allele frequencies diﬀer. There are a growing array of tools
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alternative splicing, miRNA-binding sites), but many
researchers may ﬁnd it diﬃcult to gather and employ
these algorithms. Finally, while such tools predict puta-
tive functional regions for the Reference Sequence, they
do not necessarily consider if the alternative alleles of
SNPs in that sequence are likely to have diﬀerent
consequences.
Here we describe a comprehensive web server designed
to select SNPs for genetic association studies. In designing
this application we provide 3 pipelines for SNP selection
with options to combine all three pipelines. The candidate
gene pipeline uses both a user-provided list of candidate
genes and disease-speciﬁc GWAS data [readily available
from dbGaP (www.ncbi.nlm.nih.gov/sites/entrez?db=
gap) and elsewhere] to select SNPs that are predicted to
have functional consequences and that are in high LD
with a small P-value GWAS SNP. For genes where a
large proportion of the SNPs were not in LD with any
GWAS SNP and thus are uninvestigated in the GWAS,
the web application can pick LD tag SNPs to evaluate the
untagged SNPs. The second, genomic pipeline selects
SNPs with likely functional consequences from SNPs
with small P-value in a GWAS and from SNPs in high
LD with such SNPs. The third, linkage pipeline uses
a user-provided list of linkage regions to select small
P-value GWAS SNPs for each linkage region. The web
application has information on all SNPs in HapMap and
dbSNP and automatically constructs ethnic-speciﬁc LD
relationships from both sources provided that the SNPs
have population data available. In this way, SNPs that
were not genotyped in a GWAS, but are in LD with a
SNP that was genotyped, can be screened appropriately
and GWAS data generated in one ethnic group can be
used to pick SNPs in one or more other ethnic groups.
We illustrate this application using prostate cancer as an
example in which we start with a set of a priori candidate
genes, prostate cancer GWAS data, and a set of linkage
regions, and use the pipelines to select a small panel of
1361 SNPs. We evaluate the utility of the application
against the results of a follow-up validation study that
screened a much larger panel of  27000 SNPs genotyped
in  8000 cases and controls and ﬁnd that we included ﬁve
of the seven SNPs found to be associated with prostate
cancer.
METHODS
Candidate gene pipeline
A list of candidate genes for a particular disease can be
gleaned from published association studies, gene expres-
sion studies, disease pathways and the speciﬁc interests of
an investigator. Such lists may be very large, so we ﬁrst
ﬁlter the list against GWAS results as shown in Figure 1.
We use SNPs that have genotype data in dbSNP as our
source of SNPs in and near a gene (for a user-speciﬁed
ﬂanking region around the gene). We keep a gene if it has
at least one small P-value SNP (less than or equal to a
user-speciﬁed threshold, T1) in the GWAS. We also keep
genes that were not adequately represented by SNPs in the
GWAS panel. The percent of common SNPs (within a
gene and ﬂanking region) in high LD (pairwise r
2 a
user-speciﬁed threshold) with any GWAS SNP (including
GWAS SNPs outside the gene and ﬂanking region)
is calculated and genes with coverage less than a user-
speciﬁed cutoﬀ A% are retained. Genes that do not
have SNPs with small P-value but do have suﬃcient cov-
erage by GWAS SNPs are excluded from further analysis.
For the candidate genes that pass the above screen we
extract SNPs from dbSNP and process this list as shown
in Figure 1. If a SNP was examined in the GWAS and had
a P-value less than the user-speciﬁed threshold T1 it is
retained. If a SNP was not in the GWAS but was in
high LD with a GWAS SNP that had a P-value larger
than T1 it is eliminated because we reason that it was
adequately evaluated by the GWAS and found to have
no association with disease. We then score all retained
SNPs for functional signiﬁcance and apply diﬀerent
minor allele frequency (MAF) ﬁlters depending on the
functional category of the SNP. These user-speciﬁed
MAF ﬁlters are provided because functionally important
SNPs often have lower MAF due to natural selection (6)
and we wish to provide extra ﬂexibility to retain functional
SNPs below the MAF ﬁlter being applied to SNPs without
such function. The details of the functional predictions
used in this and other pipelines are provided in a separate
section below.
In the ﬁnal processing step we select LD tag SNPs.
Because there are certain advantages to having functional
and small P-value SNPs directly assessed by the genotyp-
ing panel (instead of being indirectly assessed via LD)
we provide for the assignment of user-speciﬁed weights
for diﬀerent categories of functional SNPs and small
P-value SNPs. If weights are assigned the null value of
1, then tag SNPs are selected simply by rank order, so
that SNPs that are in high LD with the largest number
of SNPs are selected ﬁrst and SNPs that tag only them-
selves (singleton tags) are selected last. If a functional SNP
has a weight applied, then the weight act as multiplier of
the actual number of SNPs tagged so that it is more likely
to be selected early. For example, a functional SNP with a
weight of two that is in LD with four SNPs (including
itself) would have a weighted tag value of 2 4=8.
Investigators may modify a variety of values (e.g.
P-value threshold T1, LD threshold, or weights) to
adjust selected SNP counts to ﬁt their genotyping panel
size and budget. We provide two options for additional
SNP reduction that we think are useful: (i) Each SNP
must be in LD with a user-speciﬁed minimum number of
common SNPs (after multiplied by the user-assigned
weights). For example, this option can be used to elimi-
nate singleton SNPs. (ii) A user can also specify the
maximum number of SNPs that are allowed for any one
gene using a method which is similar to selecting the best
N SNPs to optimize power (7). To insure that each gene
has some coverage, we also provide a user-speciﬁed min-
imum number of best SNPs (in terms of number of SNPs
captured at a speciﬁc LD threshold) that must be selected
for each gene even if they do not meet the previous
criterion for tag SNPs.
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Small P-value GWAS SNPs were considered in the previ-
ous pipeline if they occur within a speciﬁed candidate
gene, but for those in the remainder of the genome we
provide additional means of selection based on function
and evolutionary conservation (Figure 2A). In providing
this screen we consider not only all the GWAS SNPs that
were found to have small P-values, but the much larger
set of SNPs in dbSNP that meet two criteria: (i) they
are within a user-speciﬁed distance from a small P-value
GWAS SNP; and (ii) they are known to be in high LD
with a small P-value GWAS SNP. From this large pool we
screen SNPs based on functional predictions and apply
MAF ﬁlters. Finally, we eliminate redundant SNPs
based on a user-deﬁned LD threshold.
Linkage pipeline
Linkage studies of family-based samples are another val-
uable source for candidate regions of the genome involved
in disease. GWAS panels have much higher SNP density
than linkage studies, and provide ﬁner mapping infor-
mation using large population-based samples. Within
each user-speciﬁed linkage region, we select small
P-value GWAS SNPs at a user-speciﬁed threshold, rank
them by P-value and select a user-speciﬁed number of
non-redundant SNPs (based on pairwise LD) that have
the smallest P-value (Figure 2B).
Functional SNP prediction
Depending on their position and ﬂanking sequence in a
gene, SNPs may have varied functional eﬀects on protein
sequence, transcriptional regulation, RNA splicing or
Figure 1. GenePipe: decision tree to prioritize SNPs for candidate genes based on GWAS results, SNP functional prediction characteristics and pair-
wise LD. The six-sided boxes represent decision points and rectangles represent action steps or end points.
Figure 2. (A) GenomePipe: ﬂow chart for functional SNP selection
from SNPs that are in high LD with small P-value GWAS SNPs. (B)
LinkagePipe: ﬂow chart to prioritize SNPs in linkage loci based on
P-values in GWAS.
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available for prediction of such functional regions within
genes, and we use these tools to help identify SNPs that
are more likely to aﬀect biological function. In doing so
we examine not only whether a SNP occurs within a likely
functional region, but also whether the alternative alleles
are likely to have diﬀerential functional eﬀects.
Coding SNPs. Within the coding region of a gene, we
identify nonsense SNPs that lead to premature termina-
tion of translation and are therefore very likely to aﬀect
protein function. In addition, non-synonymous poly-
morphisms (nsSNPs) that lead to amino acid changes
may also aﬀect protein function depending on the location
and nature of the amino acid substitution. We used two in
silico classiﬁcation programs, Polyphen (8) and SNPs3D
(9), to predict the eﬀect of an amino acid substitution on
the structure and function of a human protein, and then
classiﬁed nsSNPs as possibly or probably damaging or
benign.
Transcription-factor-binding sites (TFBS). If a SNP is
located at a TFBS of a gene, it may aﬀect the level or
timing of gene expression. We identiﬁed such SNPs
according to the procedure shown in Supplementary
Figure 1. For each SNP within 5 kb upstream or 1kb
downstream of a transcription start site (TSS), we ﬁrst
extracted 29 bp DNA sequence on either side of the
SNP, and then used the MATCH (10) method to predict
possible TFBSs in the resulting 59 base pair sequence
using each alternative allele. A SNP was classiﬁed as
aﬀecting TFBS activity if MATCH predicted a TFBS
with one allele but not with the other and the diﬀerence
in the matrix similarity scores (MSS) or core similarity
scores (CSS) between the two alleles was  0.2. Possible
scores for MSS and CSS range from 0 to 1 (10). We per-
formed predictions using all the 187 position weight matri-
ces classiﬁed as high quality non-redundant vertebrate
(mouse, rat and human) matrices in TRANSFAC
Release 12.1 (11). We used the default set of MATCH
score thresholds provided by TRANSFAC to allow for
10% false negative results. We also ﬁltered out SNPs in
non-conserved TFBS. To ﬁnd conserved TFBS, we ﬁrst
identiﬁed the mouse or rat homolog sequence for each
predicted TFBS in the human genome based on 17-way
vertebrate multiz alignment from UCSC genome bioinfor-
matics web site. We then ran MATCH on these homolog
sequences with the same position weight matrices.
We categorized a TFBS as conserved if both mouse and
rat homolog sequences also have the same predicted
TFBS. Several studies (12–14) show that using both the
predicted conserved TFBS together with the regulatory
potential score (13) can improve predictions, so we also
provide this option on the web server.
Splice sites. SNPs that are located within two base pairs
of an intron–exon junction, or located at exonic splicing
enhancer (ESE) or exonic splicing silencer (ESS)-binding
sites may disrupt mRNA splicing and severely aﬀect pro-
tein function (15). We predicted ESE and ESS sites using
procedure outlined in Supplementary Figure 2. If an exon
was longer than 140 base pairs, only SNPs within the ﬁrst
and last 70 base pairs of each exon were evaluated because
the eﬀect of alternative alleles on the activity of ESEs and
ESSs decrease with distance from the splice site (16,17).
We only considered a maximum of 10 base pairs on either
side of a SNP because there are no signiﬁcant compensa-
tory or correlated relationships between non-overlapping
ESE or ESS motifs (18). ESE sites were predicted using
RESCUE ESE (19) or ESEﬁnder (20) methods. ESS sites
were predicted using the FAS–ESS (21) method. A SNP
was classiﬁed as aﬀecting splicing activity if there was
at least one predicted binding site with one allele, but
none with the other allele. In order to reduce false positive
results, we excluded predicted binding sites within an exon
if, based on Ensembl transcripts isoform data, there were
no alternatively spliced transcripts observed involving
the exon. For example, suppose a gene has eight exons
and ﬁve diﬀerent transcript isoforms reported in
Ensembl. If there was a predicted ESE or ESS-binding
site in exon 3 but all ﬁve transcripts include exon 3, then
we would exclude the site.
MicroRNA-binding sites. MicroRNAs (miRNA) are
21–23-base single-stranded RNA molecules that bind to
the end of a messenger RNA (mRNA) and can inhibit
protein translation. Human miRNA is usually comple-
mentary to a site in the 30 UTR region of an mRNA.
We extracted the 20 base pair ﬂanking sequence on both
sides of SNPs in the 30 UTR region of genes. We search for
possible miRNA-binding sites on the 41 base pair DNA
sequence for each allele of a SNP using the software
miRanda (22), with default parameter values. Using the
procedure outlined in Supplementary Figures 3 and 4, we
predicted putative miRNA-binding sites for all 677 human
miRNAs in the miRBase database (23). We excluded
SNPs in miRNA-binding sites that were not conserved
in either the mouse or rat homolog sequences. We classi-
ﬁed a SNP as aﬀecting miRNA-binding site activity if the
miRanda scores for the two alleles diﬀered by  16, a value
which is equivalent to that of a SNP in the ‘seed’ region
of a miRNA-binding site.
Web server and usage
We have incorporated these methods into a user-friendly
web server: SNPinfo (http://www.niehs.nih.gov/snpinfo).
The web utility is supported by a set of optimized
mySQL databases. Depending on the speciﬁc pipeline
being used (GenePipe, GenomePipe or LinkagePipe),
an investigator may input several types of data: a list of
candidate genes, a GWAS SNP list of Reference Sequence
(rs) numbers with associated P-value from the GWAS of
interest, or a list of linkage loci.
LD relationships between SNPs may diﬀer between
ethnic groups so we have deposited, as a central resource
of our web server, the information on SNP genotype data
and pairwise LD for each ethnic group. This allows the
user to incorporate the results of a GWAS from one ethnic
group into LD tag SNP selection for one or more diﬀerent
ethnic groups. To evaluate LD relationships between
SNPs, a user can use not only pair-wise LD data
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tions in HapMap Phase III, but also has the option to
use pair wise LD based on all dbSNP genotype data for
each of ﬁve population groups (African American, Asian,
European, Hispanics and sub-Saharan African). dbSNP
genotype data includes all deposited HapMap data as
well as additional SNPs, individuals and ethnic groups.
dbSNP includes genotype data from many diﬀerent geno-
typing and resequencing eﬀorts on sometimes overlapping
sets of individuals. We combined genotypes for indivi-
duals of the same ethnic group. If multiple submitters
genotyped the same SNP in the same person and the gen-
otype calls are inconsistent, we assigned the person the
most commonly called genotype or a missing call
if they are equally split. We employed an eﬃcient
greedy algorithm that was originally implemented in
TAGster (24) to select LD tag SNP for single or multiple
populations.
In addition to the three pipelines the server provides
three additional tools. The ﬁrst of these ‘TagSNP’ allows
a user to combine the SNP lists selected from diﬀerent
pipelines and eliminate redundant SNPs based on LD
relationships and SNPs with low SNP design scores. It
also allows the user to mandate inclusion of SNPs of spe-
cial interest, or exclusion of undesired SNPs. This same
tool may be used as a stand-alone tool to ﬁnd and list
SNPs, choose LD tag SNPs, and produce high quality
LD or genotype ﬁgures for individual genes or chromo-
some regions. A second stand-alone tool, ‘FuncPred’
allows a user to query functional prediction results and
ethnic group allele frequencies for all of the SNPs in a
gene or chromosomal region, or for a list of input SNPs.
The ﬁnal tool ‘SNPseq’ allows a user to visualize SNP
related information and CpG regions in DNA sequence
context for an individual SNP, gene, or region of a chro-
mosome. This is particularly useful for PCR primer
design.
Example and validation
We have used the GWAS data from the Cancer Genetics
Markers of Susceptibility (CGEMS) project on prostate
cancer (4) to demonstrate the utility of our method. This
GWAS genotyped 550K SNPs in 1172 prostate cancer
cases and 1157 controls of European origin. We used
our web utility to construct a small SNP genotyping
panel for a genetic association study on prostate cancer
in African-American and European-American men.
Based on published candidate gene association studies,
gene expression studies, and pathway analysis we con-
structed a list of 848 candidate genes of interest in prostate
cancer. Using GenePipe, 542 genes were excluded because
none of the GWAS SNPs in these genes had a P-value
 0.05 and there were suﬃcient GWAS SNPs to capture
(at r2   0.8) more than 50% of common (MAF 0.05)
SNPs in Europeans. For the remaining 306 genes, 822
non-redundant SNPs were selected as outlined in
Figure 1 with the following GenePipe parameter values:
gene upstream region=5kb, gene downstream
region=1kb, MAF=0.05 for all SNPs, weight=3 for
any predicted functional SNP and small P-value SNPs,
weight=1 for all other SNPs, r
2 threshold=0.8, mini-
mum number of SNPs tagged by each selected tag
SNP=3, minimum number of tag SNPs/gene=1, and
maximum number of tag SNPs/gene=5.
The CGEMS GWAS reported 6034 GWAS SNPs with
P 0.01. GenomePipe identiﬁed 41755 SNPs that are in
high LD with these GWAS SNPs (r
2 0.8), and from the
41755 SNPs selected 543 common SNPs (MAF 0.05)
that were predicted to be functional by at least one of
the prediction methods.
Published studies have identiﬁed 43 non-overlapping
linkage regions for prostate cancer. As shown in
Figure 2B, we used LinkagePipe to select 266 GWAS
SNPs using the following parameter values (MAF=
0.05, Maximum number of SNPs/linkage locus=7,
GWAS P threshold=0.01, LD threshold=0.8).
The resulting SNP lists from GenePipe, GenomePipe
and LinkagePipe were combined and we used TagSNP
to eliminate duplicate and redundant SNPs, or SNPs
with low assay design scores, yielding a set of 1361
SNPs. Of these, 709 (52%) were GWAS SNPs and the
remaining 48% were new SNPs not in the GWAS which
were selected to provide additional functional examina-
tion of genes.
Although the selection algorithm used the P-value data
for 550K SNPs from the CGEMS GWAS, we did not, in
this example, use information from other GWAS data sets
or from the validation portion of the CGEMS initial study
(4). The CGEMS follow up study was particularly robust
because it genotyped 26 958 SNPs, including all SNPs with
P-value <0.068 from the initial CGEMS GWAS, in 3941
cases and 3964 controls (5). This provides an unbiased
opportunity to evaluate whether the very small set of
SNPs selected by our algorithm include the SNPs vali-
dated in a genotyping panel that was many times larger.
The CGEMS validation study identiﬁed seven prostate
cancer related SNPs which had P-value ranks in the initial
GWAS ranging from 116 (P=0.0004) to 24407
(P=0.042). Our algorithms selected ﬁve (71%) of those
seven SNPs. Three of the ﬁve SNPs were selected by
GenePipe, one was selected by GenomePipe and three
were selected by LinkagePipe. Of the two SNPs that
were missed, rs10486567 in JAZF1 was not in our candi-
date gene list because at the time we constructed the gene
list, JAZF1 had not previously been reported in the liter-
ature as having any association with prostate cancer. The
other SNP, rs10896449, was not located in a known gene
or linkage region. Although the very small panel of SNPs
selected by the algorithm cannot substitute for massive
follow-up genotyping, it performs very well with 2.5%
(709 vs. 26958) of the GWAS SNPs, and in addition ded-
icates almost half of the SNPs to new functional and can-
didate gene polymorphisms that were unexplored in the
half million GWAS SNP panel.
DISCUSSION
SNP selection for an association study can be a complex
problem. Decades of diverse investigation provide a tre-
mendous amount of information on genes, pathways, and
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GWAS oﬀers an agnostic approach to investigating
SNP-disease association, and the results of such studies
oﬀers a wealth of data to inform the next generation of
investigation. Here, we develop a user-friendly web server
to incorporate such clinical, experimental, mechanistic,
and computational information with the results of
GWAS in order to organize, annotate, and select SNPs.
The web server can be used for either small or large-scale
SNP selection and is particularly useful for association
studies. It uses both functional prediction and GWAS
results to select not only SNPs included in the GWAS,
but other functional SNPs in dbSNP that were not in
the GWAS. Considering the varied interests and emphasis
diﬀerent investigators may bring to a problem, we pro-
vided many tunable parameters in each web utility, so
the algorithm can be adjusted to meet diﬀerent needs.
We employ several methods for functional sequence
assessment and predict functional consequence of diﬀerent
alleles of a SNP. To reduce the number of false positive
results, we perform the predictions in only the most prob-
able genomic regions for each category of functional
sequence site (such as the gene promoter region for TFBS
or the 30 UTR for microRNA-binding sites) and use phy-
logenetic footprint information to ﬁlter out non-conserved
putative functional sequence. The SNP selection algorithm
uses functional prediction results to prioritize LD tag SNP
selection. These LD tag SNPs capture other unexamined
SNPs in and around a gene, including SNPs with unknown
or unpredicted functional consequences. The web utility
options allow aninvestigator to choose prediction methods
and assign weights to those predictions for study-speciﬁc
SNP selection. Functional sequence prediction is a rapidly
developing ﬁeld. The web server structure allows rapid
updates as better methods of functional prediction
become available and it allows expansion to include pre-
dictions on other biologic functions.
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